(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 11.91% to €5.26 on Friday, following the last session’s downward trend. BEL 20 dropped 1.15% to €3,438.86, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
NYXOAH’s last close was €4.70, 49.24% below its 52-week high of €9.26.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.66.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.86%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NYXOAH’s EBITDA is -10.41.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NYXOAH’s stock is considered to be overbought (>=80).
Sales Growth
NYXOAH’s sales growth is 658.2% for the present quarter and 44.6% for the next.
More news about NYXOAH (NYXH.BR).
